Expression and function of TRAF-3 splice-variant isoforms in human lymphoma cell lines

Human Immunology

Volumn 62, Issue 10, 2001, Pages 1167-1177

  Gamper, Christopher ^a   Omene, Coral O ^a   Van Eyndhoven, Winfried G ^a   Glassman, Grace D ^a   Lederman, Seth ^a,b  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Laboratory of Molecular Immunology   (United States)

Author keywords

Cell surface molecules; Human; Molecular biology; Signal transduction; T cell B cell collaboration

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOPROTEIN; MESSENGER RNA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CELL INTERACTION; CELL STRAIN; CONTROLLED STUDY; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOMA CELL LINE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIBONUCLEASE PROTECTION ASSAY; RNA SPLICING; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ALTERNATIVE SPLICING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; JURKAT CELLS; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; NF-KAPPA B; PROTEIN BIOSYNTHESIS; PROTEIN ISOFORMS; PROTEINS; RIBONUCLEASES; SEQUENCE DELETION; TNF RECEPTOR-ASSOCIATED FACTOR 3; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034792350     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(01)00284-1     Document Type: Article

References (37)

1. A novel RING finger protein interacts with the cytoplasmic domain of CD40
2. Involvement of CRAF1, a relative of TRAF, in CD40 signaling
3. A novel member of the TRAF family of putative signal transducing proteins binds to the cytosolic domain of CD40
4. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family
5. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins
6. Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily
7. Lymphotoxin-beta receptor signaling complex: Role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor κB
8. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB
9. Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-κB activation
10. Immunohistochemical analysis of in vivo patterns of TRAF-3 expression, a member of the TNF receptor-associated factor family
11. A single gene for human TRAF-3 at chromosome 14q32.3 encodes a variety of mRNA species by alternative polyadenylation, mRNA splicing and transcription initiation
12. TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-κB activation
13. TRAF2-mediated activation of NF-κ-B by TNF Receptor 2 and CD40
14. TRAF5, an activator of NK-kappaB and putative signal transducer for the lymphotoxin-β receptor
15. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling
16. Tumor necrosis factor receptor (TNRF)-associated factor 2A (TRAF2A), a TRAF2 splice variant with an extended RING finger domain that inhibits TNFR2-mediated NF-κB activation
17. Complete structural characterisation of the mammalian and Drosophila TRAF genes: Implications for TRAF evolution and the role of RING finger splice variants
18. Identification of a novel surface protein on activated CD4+ T cells that induces contact dependent B cell differentiation (help)
19. Membrane localization of TRAF 3 enables JNK activation
20. Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling
21. An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-κB activation but is dispensable for c-Jun N-terminal kinase signaling
22. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization
23. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1
24. Defective lymphotoxin-beta receptor-induced NF-κB transcriptional activity in NIK-deficient mice
25. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
26. Signaling by proinflammatory cytokines: Oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain
27. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38
28. Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-κB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway
29. TANK potentiates tumor necrosis factor receptor-associated factor-mediated c-Jun N-terminal kinase/stress-activated protein kinase activation through the germinal center kinase pathway
30. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: Regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization
31. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-κB and Jun N-terminal kinase activation
32. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation
33. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses
34. The regulation of splice-site selection, and its role in human disease
35. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression
36. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)
37. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome